每周股票复盘：天臣医疗（688013）将召开业绩说明会

Core Points - Tianchen Medical (688013) stock price increased by 17.76% to 67.25 CNY as of September 12, 2025, reaching a nearly one-year high of 68.0 CNY during the week [1] - The company's total market capitalization is 5.484 billion CNY, ranking 66th out of 126 in the medical device sector and 3074th out of 5153 in the A-share market [1] Company Announcements - Tianchen Medical will participate in the 2025 semi-annual performance briefing for the medical device industry on September 17, 2025, with key executives present for investor interaction [1][4] - The company approved a proposal to use up to 200 million CNY of temporarily idle raised funds for cash management, with a usage period of 12 months [2][4] - The company and its subsidiaries plan to apply for a total credit limit of up to 300 million CNY from banks within 12 months [2][4] - The company’s shareholders meeting approved the 2025 annual audit firm reappointment and the 2025 semi-annual profit distribution plan, with over 99.98% approval from ordinary shareholders [2][4]